Lpl Financial LLC Abb Vie Inc. Put Options Transaction History

Lpl Financial LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $20,460 - $22,524	200 Added 8.0%	2,700 $292,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $14,674 - $19,636	-200 Reduced 7.41%	2,500 $245,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $887,199 - $1.11 Million	-12,300 Reduced 82.0%	2,700 $239,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $453,330 - $579,462	6,900 Added 85.19%	15,000 $1.09 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $46,005 - $61,605	-500 Reduced 5.81%	8,100 $767,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $770,216 - $844,606	8,600	8,600 $832,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.